Document is current

Article History

Received: 22 December 2024

Accepted: 13 March 2025

First Online: 24 March 2025

Declarations

:

: The study was designed in accordance with legal and regulatory requirements (Belgian Law of 7 May 2004, Patient Rights (08/2002), Privacy (RD 2001), HBM (Human Body Material, Law of 19 December 2008)), as well as the Guidelines for Good Clinical Practice (International Conference on Harmonization, 1996), and the latest version of the Declaration of Helsinki (World Medical Association). The protocol was approved by the referring local ethics committee (Erasme University Hospital, Belgium) as minimal-risk research using data collected for routine clinical practice n°P2021/360/B4062021000188. Patients or their representatives provided written informed consent for inclusion in the trial and had the option to refuse participation.

: Not applicable.

: C.B was supported by a grant from Université de Lille, France. F.P. & M.R. were supported by F.R.S.-FNRS Fund for Scientific Research. B.G. was supported by a grant from ISICEM asbl. F.A was supported by the Fonds Erasme. AP reports research grants from 4TEEN4 pharmaceuticals, the Société de Réanimation de Langue Française, Société Française d’Anesthésie-Réanimation, Zoll fondation and the Fonds pour la chirurgie cardiaque outside the scope of the submitted work. ML is supported by grant R01-GM151494-01 and R01DK139484-01 from the NIH and received consulting fees from Alexion, Radiometer, Viatris and La Jolla.